strategic alternatives
Qiagen Completes Strategic Review, Rejects Acquisition Offers
The firm had received interest from unnamed potential acquisition partners following the departure of its CEO, but it has decided to remain as a standalone business.
Curetis Hires Strategic Advisor, Delays Release of Financial Results
The company is delaying the publication of its business and financial update for the first half of 2019 to allow for an ongoing review by its auditors.
Enzo Biochem Fiscal Q3 Revenues Decline 22 Percent
The company's clinical services revenues were down 34 percent year over year while product revenues ticked up 7 percent.
Cancer Genetics Selling Indian Subsidiary to Reprocell for up to $1.9M
The firm is selling BioServe to Reprocell as part of Cancer Genetics' transformation and strategic plan to bring itself to profitability.
Class Action Lawsuits Filed Against Cancer Genetics
The lawsuits allege the company made false and/or misleading statement and/or failed to disclose information that was pertinent to investors.
Apr 2, 2018
Cancer Genetics Q4 Revenues Grow 4 Percent
Nov 19, 2012